EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis

Chenghao Wu, Shaobo Yu, Yanzhong Wang, Yuzhen Gao, Xinyou Xie, Jun Zhang

Frontiers in Pharmacology · 31.08.2023 · 14

DOI: 10.3389/fphar.2023.1212420 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 31.08.2023. Verfasst von Chenghao Wu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer liver metastasis is a major risk factor of poor outcomes, necessitating proactive interventions and treatments. Cancer-associated fibroblasts (CAFs) play essential roles in metastasis, with a focus on metabolic reprogramming. However, knowledge about associations between Cancer-associated fibroblasts metabolic phenotypes and immune cell is limited. This study uses single-cell and bulk transcriptomics data to decode roles of metabolism-related subtype of Cancer-associated fibroblasts and immune cells in liver metastasis, developing a CAF-related prognostic model for colorectal cancer liver metastases.

Methods

In this study, Cancer-associated fibroblasts metabolism-related phenotypes were screened using comprehensive datasets from The Cancer Genome Atlas and gene expression omnibus (GEO). Cox regression and Lasso regression were applied to identify prognostic genes related to Cancer-associated fibroblasts, and a model was constructed based on the Cancer-associated fibroblasts subtype gene score. Subsequently, functional, immunological, and clinical analyses were performed.

Results

The study demonstrated the metabotropic heterogeneity of Cancer-associated fibroblasts cells. Cancer-associated fibroblasts cells with varying metabolic states were found to exhibit significant differences in communications with different immune cells. Prognostic features based on Cancer-associated fibroblasts signature scores were found to be useful in determining the prognostic status of colorectal cancer patients with liver metastases. High immune activity and an enrichment of tumor-related pathways were observed in samples with high Cancer-associated fibroblasts signature scores. Furthermore, Cancer-associated fibroblasts signature score could be practical in guiding the selection of chemotherapeutic agents with higher sensitivity.

Conclusion

Our study identified a prognostic signature linked to metabotropic subtype of Cancer-associated fibroblasts. This signature has promising clinical implications in precision therapy for colorectal cancer liver metastases.

Schlagwörter

Stichwörter der Autor:innen

cancer-associated fibroblastscolorectal cancer liver metastases (CRLM)immunity therapymetabolismsingle cell transcriptome

Autor:innen und Institutionen

  • Department of Clinical Laboratory, Sir Run Run Shaw Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, Zhejiang, China.

Zitieren

APA

Wu, C., Yu, S., Wang, Y., Gao, Y., Xie, X., & Zhang, J. (2023). Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1212420

Vancouver

Wu C, Yu S, Wang Y, Gao Y, Xie X, Zhang J. Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1212420

BibTeX
@article{Wu2023,
  author = {Wu, Chenghao and Yu, Shaobo and Wang, Yanzhong and Gao, Yuzhen and Xie, Xinyou and Zhang, Jun},
  title = {Metabolic-suppressed cancer-associated fibroblasts limit the immune environment and survival in colorectal cancer with liver metastasis},
  journal = {Frontiers in Pharmacology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fphar.2023.1212420}
}
Kostenlos starten →